Global Tumor Genomics Market Research Report 2024(Status and Outlook)
Report Overview
Tumor genomics, also known as cancer genomics, is an emerging sub-discipline in genomics, mainly through the high-throughput sequencing technology to associate genes with cancer. Tumor is a disease caused by the accumulation of DNA mutations that leads to an uncontrolled proliferation of cells and the formation of new organisms. The main goal of tumor genomics is to provide new methods for tumor diagnosis, tumor clinical outcome prediction and tumor target treatment by identifying new oncogenes or tumor suppressor genes.
This report provides a deep insight into the global Tumor Genomics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tumor Genomics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tumor Genomics market in any manner.
Global Tumor Genomics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
Illumina, Inc.
Merck KGaA
Myriad Genetics, Inc.
Pacific Biosciences of California, Inc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Market Segmentation (by Type)
Assays and Kits
Instrument
Market Segmentation (by Application)
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tumor Genomics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Tumor genomics, also known as cancer genomics, is an emerging sub-discipline in genomics, mainly through the high-throughput sequencing technology to associate genes with cancer. Tumor is a disease caused by the accumulation of DNA mutations that leads to an uncontrolled proliferation of cells and the formation of new organisms. The main goal of tumor genomics is to provide new methods for tumor diagnosis, tumor clinical outcome prediction and tumor target treatment by identifying new oncogenes or tumor suppressor genes.
This report provides a deep insight into the global Tumor Genomics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tumor Genomics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tumor Genomics market in any manner.
Global Tumor Genomics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
Illumina, Inc.
Merck KGaA
Myriad Genetics, Inc.
Pacific Biosciences of California, Inc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Market Segmentation (by Type)
Assays and Kits
Instrument
Market Segmentation (by Application)
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Tumor Genomics Market
- Overview of the regional outlook of the Tumor Genomics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tumor Genomics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Tumor Genomics
1.2 Key Market Segments
1.2.1 Tumor Genomics Segment by Type
1.2.2 Tumor Genomics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUMOR GENOMICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tumor Genomics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tumor Genomics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUMOR GENOMICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Tumor Genomics Sales by Manufacturers (2019-2024)
3.2 Global Tumor Genomics Revenue Market Share by Manufacturers (2019-2024)
3.3 Tumor Genomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tumor Genomics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tumor Genomics Sales Sites, Area Served, Product Type
3.6 Tumor Genomics Market Competitive Situation and Trends
3.6.1 Tumor Genomics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tumor Genomics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TUMOR GENOMICS INDUSTRY CHAIN ANALYSIS
4.1 Tumor Genomics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUMOR GENOMICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TUMOR GENOMICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tumor Genomics Sales Market Share by Type (2019-2024)
6.3 Global Tumor Genomics Market Size Market Share by Type (2019-2024)
6.4 Global Tumor Genomics Price by Type (2019-2024)
7 TUMOR GENOMICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tumor Genomics Market Sales by Application (2019-2024)
7.3 Global Tumor Genomics Market Size (M USD) by Application (2019-2024)
7.4 Global Tumor Genomics Sales Growth Rate by Application (2019-2024)
8 TUMOR GENOMICS MARKET SEGMENTATION BY REGION
8.1 Global Tumor Genomics Sales by Region
8.1.1 Global Tumor Genomics Sales by Region
8.1.2 Global Tumor Genomics Sales Market Share by Region
8.2 North America
8.2.1 North America Tumor Genomics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tumor Genomics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tumor Genomics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tumor Genomics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tumor Genomics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Tumor Genomics Basic Information
9.1.2 Abbott Laboratories Tumor Genomics Product Overview
9.1.3 Abbott Laboratories Tumor Genomics Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Tumor Genomics SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Agilent Technologies, Inc
9.2.1 Agilent Technologies, Inc Tumor Genomics Basic Information
9.2.2 Agilent Technologies, Inc Tumor Genomics Product Overview
9.2.3 Agilent Technologies, Inc Tumor Genomics Product Market Performance
9.2.4 Agilent Technologies, Inc Business Overview
9.2.5 Agilent Technologies, Inc Tumor Genomics SWOT Analysis
9.2.6 Agilent Technologies, Inc Recent Developments
9.3 Bio-Rad Laboratories, Inc.
9.3.1 Bio-Rad Laboratories, Inc. Tumor Genomics Basic Information
9.3.2 Bio-Rad Laboratories, Inc. Tumor Genomics Product Overview
9.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Product Market Performance
9.3.4 Bio-Rad Laboratories, Inc. Tumor Genomics SWOT Analysis
9.3.5 Bio-Rad Laboratories, Inc. Business Overview
9.3.6 Bio-Rad Laboratories, Inc. Recent Developments
9.4 Danaher Corporation
9.4.1 Danaher Corporation Tumor Genomics Basic Information
9.4.2 Danaher Corporation Tumor Genomics Product Overview
9.4.3 Danaher Corporation Tumor Genomics Product Market Performance
9.4.4 Danaher Corporation Business Overview
9.4.5 Danaher Corporation Recent Developments
9.5 F. Hoffmann-La Roche Ltd
9.5.1 F. Hoffmann-La Roche Ltd Tumor Genomics Basic Information
9.5.2 F. Hoffmann-La Roche Ltd Tumor Genomics Product Overview
9.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Product Market Performance
9.5.4 F. Hoffmann-La Roche Ltd Business Overview
9.5.5 F. Hoffmann-La Roche Ltd Recent Developments
9.6 Fluidigm Corporation
9.6.1 Fluidigm Corporation Tumor Genomics Basic Information
9.6.2 Fluidigm Corporation Tumor Genomics Product Overview
9.6.3 Fluidigm Corporation Tumor Genomics Product Market Performance
9.6.4 Fluidigm Corporation Business Overview
9.6.5 Fluidigm Corporation Recent Developments
9.7 General Electric Company
9.7.1 General Electric Company Tumor Genomics Basic Information
9.7.2 General Electric Company Tumor Genomics Product Overview
9.7.3 General Electric Company Tumor Genomics Product Market Performance
9.7.4 General Electric Company Business Overview
9.7.5 General Electric Company Recent Developments
9.8 Illumina, Inc.
9.8.1 Illumina, Inc. Tumor Genomics Basic Information
9.8.2 Illumina, Inc. Tumor Genomics Product Overview
9.8.3 Illumina, Inc. Tumor Genomics Product Market Performance
9.8.4 Illumina, Inc. Business Overview
9.8.5 Illumina, Inc. Recent Developments
9.9 Merck KGaA
9.9.1 Merck KGaA Tumor Genomics Basic Information
9.9.2 Merck KGaA Tumor Genomics Product Overview
9.9.3 Merck KGaA Tumor Genomics Product Market Performance
9.9.4 Merck KGaA Business Overview
9.9.5 Merck KGaA Recent Developments
9.10 Myriad Genetics, Inc.
9.10.1 Myriad Genetics, Inc. Tumor Genomics Basic Information
9.10.2 Myriad Genetics, Inc. Tumor Genomics Product Overview
9.10.3 Myriad Genetics, Inc. Tumor Genomics Product Market Performance
9.10.4 Myriad Genetics, Inc. Business Overview
9.10.5 Myriad Genetics, Inc. Recent Developments
9.11 Pacific Biosciences of California, Inc.
9.11.1 Pacific Biosciences of California, Inc. Tumor Genomics Basic Information
9.11.2 Pacific Biosciences of California, Inc. Tumor Genomics Product Overview
9.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Product Market Performance
9.11.4 Pacific Biosciences of California, Inc. Business Overview
9.11.5 Pacific Biosciences of California, Inc. Recent Developments
9.12 PerkinElmer
9.12.1 PerkinElmer Tumor Genomics Basic Information
9.12.2 PerkinElmer Tumor Genomics Product Overview
9.12.3 PerkinElmer Tumor Genomics Product Market Performance
9.12.4 PerkinElmer Business Overview
9.12.5 PerkinElmer Recent Developments
9.13 QIAGEN
9.13.1 QIAGEN Tumor Genomics Basic Information
9.13.2 QIAGEN Tumor Genomics Product Overview
9.13.3 QIAGEN Tumor Genomics Product Market Performance
9.13.4 QIAGEN Business Overview
9.13.5 QIAGEN Recent Developments
9.14 Siemens Healthineers AG
9.14.1 Siemens Healthineers AG Tumor Genomics Basic Information
9.14.2 Siemens Healthineers AG Tumor Genomics Product Overview
9.14.3 Siemens Healthineers AG Tumor Genomics Product Market Performance
9.14.4 Siemens Healthineers AG Business Overview
9.14.5 Siemens Healthineers AG Recent Developments
9.15 Thermo Fisher Scientific Inc.
9.15.1 Thermo Fisher Scientific Inc. Tumor Genomics Basic Information
9.15.2 Thermo Fisher Scientific Inc. Tumor Genomics Product Overview
9.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Product Market Performance
9.15.4 Thermo Fisher Scientific Inc. Business Overview
9.15.5 Thermo Fisher Scientific Inc. Recent Developments
10 TUMOR GENOMICS MARKET FORECAST BY REGION
10.1 Global Tumor Genomics Market Size Forecast
10.2 Global Tumor Genomics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tumor Genomics Market Size Forecast by Country
10.2.3 Asia Pacific Tumor Genomics Market Size Forecast by Region
10.2.4 South America Tumor Genomics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tumor Genomics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Tumor Genomics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tumor Genomics by Type (2025-2030)
11.1.2 Global Tumor Genomics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tumor Genomics by Type (2025-2030)
11.2 Global Tumor Genomics Market Forecast by Application (2025-2030)
11.2.1 Global Tumor Genomics Sales (K Units) Forecast by Application
11.2.2 Global Tumor Genomics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Tumor Genomics
1.2 Key Market Segments
1.2.1 Tumor Genomics Segment by Type
1.2.2 Tumor Genomics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUMOR GENOMICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tumor Genomics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tumor Genomics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUMOR GENOMICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Tumor Genomics Sales by Manufacturers (2019-2024)
3.2 Global Tumor Genomics Revenue Market Share by Manufacturers (2019-2024)
3.3 Tumor Genomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tumor Genomics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tumor Genomics Sales Sites, Area Served, Product Type
3.6 Tumor Genomics Market Competitive Situation and Trends
3.6.1 Tumor Genomics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tumor Genomics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TUMOR GENOMICS INDUSTRY CHAIN ANALYSIS
4.1 Tumor Genomics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUMOR GENOMICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TUMOR GENOMICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tumor Genomics Sales Market Share by Type (2019-2024)
6.3 Global Tumor Genomics Market Size Market Share by Type (2019-2024)
6.4 Global Tumor Genomics Price by Type (2019-2024)
7 TUMOR GENOMICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tumor Genomics Market Sales by Application (2019-2024)
7.3 Global Tumor Genomics Market Size (M USD) by Application (2019-2024)
7.4 Global Tumor Genomics Sales Growth Rate by Application (2019-2024)
8 TUMOR GENOMICS MARKET SEGMENTATION BY REGION
8.1 Global Tumor Genomics Sales by Region
8.1.1 Global Tumor Genomics Sales by Region
8.1.2 Global Tumor Genomics Sales Market Share by Region
8.2 North America
8.2.1 North America Tumor Genomics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tumor Genomics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tumor Genomics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tumor Genomics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tumor Genomics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Tumor Genomics Basic Information
9.1.2 Abbott Laboratories Tumor Genomics Product Overview
9.1.3 Abbott Laboratories Tumor Genomics Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Tumor Genomics SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Agilent Technologies, Inc
9.2.1 Agilent Technologies, Inc Tumor Genomics Basic Information
9.2.2 Agilent Technologies, Inc Tumor Genomics Product Overview
9.2.3 Agilent Technologies, Inc Tumor Genomics Product Market Performance
9.2.4 Agilent Technologies, Inc Business Overview
9.2.5 Agilent Technologies, Inc Tumor Genomics SWOT Analysis
9.2.6 Agilent Technologies, Inc Recent Developments
9.3 Bio-Rad Laboratories, Inc.
9.3.1 Bio-Rad Laboratories, Inc. Tumor Genomics Basic Information
9.3.2 Bio-Rad Laboratories, Inc. Tumor Genomics Product Overview
9.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Product Market Performance
9.3.4 Bio-Rad Laboratories, Inc. Tumor Genomics SWOT Analysis
9.3.5 Bio-Rad Laboratories, Inc. Business Overview
9.3.6 Bio-Rad Laboratories, Inc. Recent Developments
9.4 Danaher Corporation
9.4.1 Danaher Corporation Tumor Genomics Basic Information
9.4.2 Danaher Corporation Tumor Genomics Product Overview
9.4.3 Danaher Corporation Tumor Genomics Product Market Performance
9.4.4 Danaher Corporation Business Overview
9.4.5 Danaher Corporation Recent Developments
9.5 F. Hoffmann-La Roche Ltd
9.5.1 F. Hoffmann-La Roche Ltd Tumor Genomics Basic Information
9.5.2 F. Hoffmann-La Roche Ltd Tumor Genomics Product Overview
9.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Product Market Performance
9.5.4 F. Hoffmann-La Roche Ltd Business Overview
9.5.5 F. Hoffmann-La Roche Ltd Recent Developments
9.6 Fluidigm Corporation
9.6.1 Fluidigm Corporation Tumor Genomics Basic Information
9.6.2 Fluidigm Corporation Tumor Genomics Product Overview
9.6.3 Fluidigm Corporation Tumor Genomics Product Market Performance
9.6.4 Fluidigm Corporation Business Overview
9.6.5 Fluidigm Corporation Recent Developments
9.7 General Electric Company
9.7.1 General Electric Company Tumor Genomics Basic Information
9.7.2 General Electric Company Tumor Genomics Product Overview
9.7.3 General Electric Company Tumor Genomics Product Market Performance
9.7.4 General Electric Company Business Overview
9.7.5 General Electric Company Recent Developments
9.8 Illumina, Inc.
9.8.1 Illumina, Inc. Tumor Genomics Basic Information
9.8.2 Illumina, Inc. Tumor Genomics Product Overview
9.8.3 Illumina, Inc. Tumor Genomics Product Market Performance
9.8.4 Illumina, Inc. Business Overview
9.8.5 Illumina, Inc. Recent Developments
9.9 Merck KGaA
9.9.1 Merck KGaA Tumor Genomics Basic Information
9.9.2 Merck KGaA Tumor Genomics Product Overview
9.9.3 Merck KGaA Tumor Genomics Product Market Performance
9.9.4 Merck KGaA Business Overview
9.9.5 Merck KGaA Recent Developments
9.10 Myriad Genetics, Inc.
9.10.1 Myriad Genetics, Inc. Tumor Genomics Basic Information
9.10.2 Myriad Genetics, Inc. Tumor Genomics Product Overview
9.10.3 Myriad Genetics, Inc. Tumor Genomics Product Market Performance
9.10.4 Myriad Genetics, Inc. Business Overview
9.10.5 Myriad Genetics, Inc. Recent Developments
9.11 Pacific Biosciences of California, Inc.
9.11.1 Pacific Biosciences of California, Inc. Tumor Genomics Basic Information
9.11.2 Pacific Biosciences of California, Inc. Tumor Genomics Product Overview
9.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Product Market Performance
9.11.4 Pacific Biosciences of California, Inc. Business Overview
9.11.5 Pacific Biosciences of California, Inc. Recent Developments
9.12 PerkinElmer
9.12.1 PerkinElmer Tumor Genomics Basic Information
9.12.2 PerkinElmer Tumor Genomics Product Overview
9.12.3 PerkinElmer Tumor Genomics Product Market Performance
9.12.4 PerkinElmer Business Overview
9.12.5 PerkinElmer Recent Developments
9.13 QIAGEN
9.13.1 QIAGEN Tumor Genomics Basic Information
9.13.2 QIAGEN Tumor Genomics Product Overview
9.13.3 QIAGEN Tumor Genomics Product Market Performance
9.13.4 QIAGEN Business Overview
9.13.5 QIAGEN Recent Developments
9.14 Siemens Healthineers AG
9.14.1 Siemens Healthineers AG Tumor Genomics Basic Information
9.14.2 Siemens Healthineers AG Tumor Genomics Product Overview
9.14.3 Siemens Healthineers AG Tumor Genomics Product Market Performance
9.14.4 Siemens Healthineers AG Business Overview
9.14.5 Siemens Healthineers AG Recent Developments
9.15 Thermo Fisher Scientific Inc.
9.15.1 Thermo Fisher Scientific Inc. Tumor Genomics Basic Information
9.15.2 Thermo Fisher Scientific Inc. Tumor Genomics Product Overview
9.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Product Market Performance
9.15.4 Thermo Fisher Scientific Inc. Business Overview
9.15.5 Thermo Fisher Scientific Inc. Recent Developments
10 TUMOR GENOMICS MARKET FORECAST BY REGION
10.1 Global Tumor Genomics Market Size Forecast
10.2 Global Tumor Genomics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tumor Genomics Market Size Forecast by Country
10.2.3 Asia Pacific Tumor Genomics Market Size Forecast by Region
10.2.4 South America Tumor Genomics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tumor Genomics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Tumor Genomics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tumor Genomics by Type (2025-2030)
11.1.2 Global Tumor Genomics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tumor Genomics by Type (2025-2030)
11.2 Global Tumor Genomics Market Forecast by Application (2025-2030)
11.2.1 Global Tumor Genomics Sales (K Units) Forecast by Application
11.2.2 Global Tumor Genomics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tumor Genomics Market Size Comparison by Region (M USD)
Table 5. Global Tumor Genomics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Tumor Genomics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tumor Genomics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tumor Genomics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2022)
Table 10. Global Market Tumor Genomics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tumor Genomics Sales Sites and Area Served
Table 12. Manufacturers Tumor Genomics Product Type
Table 13. Global Tumor Genomics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tumor Genomics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tumor Genomics Market Challenges
Table 22. Global Tumor Genomics Sales by Type (K Units)
Table 23. Global Tumor Genomics Market Size by Type (M USD)
Table 24. Global Tumor Genomics Sales (K Units) by Type (2019-2024)
Table 25. Global Tumor Genomics Sales Market Share by Type (2019-2024)
Table 26. Global Tumor Genomics Market Size (M USD) by Type (2019-2024)
Table 27. Global Tumor Genomics Market Size Share by Type (2019-2024)
Table 28. Global Tumor Genomics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Tumor Genomics Sales (K Units) by Application
Table 30. Global Tumor Genomics Market Size by Application
Table 31. Global Tumor Genomics Sales by Application (2019-2024) & (K Units)
Table 32. Global Tumor Genomics Sales Market Share by Application (2019-2024)
Table 33. Global Tumor Genomics Sales by Application (2019-2024) & (M USD)
Table 34. Global Tumor Genomics Market Share by Application (2019-2024)
Table 35. Global Tumor Genomics Sales Growth Rate by Application (2019-2024)
Table 36. Global Tumor Genomics Sales by Region (2019-2024) & (K Units)
Table 37. Global Tumor Genomics Sales Market Share by Region (2019-2024)
Table 38. North America Tumor Genomics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Tumor Genomics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Tumor Genomics Sales by Region (2019-2024) & (K Units)
Table 41. South America Tumor Genomics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Tumor Genomics Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Laboratories Tumor Genomics Basic Information
Table 44. Abbott Laboratories Tumor Genomics Product Overview
Table 45. Abbott Laboratories Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Laboratories Business Overview
Table 47. Abbott Laboratories Tumor Genomics SWOT Analysis
Table 48. Abbott Laboratories Recent Developments
Table 49. Agilent Technologies, Inc Tumor Genomics Basic Information
Table 50. Agilent Technologies, Inc Tumor Genomics Product Overview
Table 51. Agilent Technologies, Inc Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Agilent Technologies, Inc Business Overview
Table 53. Agilent Technologies, Inc Tumor Genomics SWOT Analysis
Table 54. Agilent Technologies, Inc Recent Developments
Table 55. Bio-Rad Laboratories, Inc. Tumor Genomics Basic Information
Table 56. Bio-Rad Laboratories, Inc. Tumor Genomics Product Overview
Table 57. Bio-Rad Laboratories, Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bio-Rad Laboratories, Inc. Tumor Genomics SWOT Analysis
Table 59. Bio-Rad Laboratories, Inc. Business Overview
Table 60. Bio-Rad Laboratories, Inc. Recent Developments
Table 61. Danaher Corporation Tumor Genomics Basic Information
Table 62. Danaher Corporation Tumor Genomics Product Overview
Table 63. Danaher Corporation Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Danaher Corporation Business Overview
Table 65. Danaher Corporation Recent Developments
Table 66. F. Hoffmann-La Roche Ltd Tumor Genomics Basic Information
Table 67. F. Hoffmann-La Roche Ltd Tumor Genomics Product Overview
Table 68. F. Hoffmann-La Roche Ltd Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. F. Hoffmann-La Roche Ltd Business Overview
Table 70. F. Hoffmann-La Roche Ltd Recent Developments
Table 71. Fluidigm Corporation Tumor Genomics Basic Information
Table 72. Fluidigm Corporation Tumor Genomics Product Overview
Table 73. Fluidigm Corporation Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Fluidigm Corporation Business Overview
Table 75. Fluidigm Corporation Recent Developments
Table 76. General Electric Company Tumor Genomics Basic Information
Table 77. General Electric Company Tumor Genomics Product Overview
Table 78. General Electric Company Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. General Electric Company Business Overview
Table 80. General Electric Company Recent Developments
Table 81. Illumina, Inc. Tumor Genomics Basic Information
Table 82. Illumina, Inc. Tumor Genomics Product Overview
Table 83. Illumina, Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Illumina, Inc. Business Overview
Table 85. Illumina, Inc. Recent Developments
Table 86. Merck KGaA Tumor Genomics Basic Information
Table 87. Merck KGaA Tumor Genomics Product Overview
Table 88. Merck KGaA Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Merck KGaA Business Overview
Table 90. Merck KGaA Recent Developments
Table 91. Myriad Genetics, Inc. Tumor Genomics Basic Information
Table 92. Myriad Genetics, Inc. Tumor Genomics Product Overview
Table 93. Myriad Genetics, Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Myriad Genetics, Inc. Business Overview
Table 95. Myriad Genetics, Inc. Recent Developments
Table 96. Pacific Biosciences of California, Inc. Tumor Genomics Basic Information
Table 97. Pacific Biosciences of California, Inc. Tumor Genomics Product Overview
Table 98. Pacific Biosciences of California, Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pacific Biosciences of California, Inc. Business Overview
Table 100. Pacific Biosciences of California, Inc. Recent Developments
Table 101. PerkinElmer Tumor Genomics Basic Information
Table 102. PerkinElmer Tumor Genomics Product Overview
Table 103. PerkinElmer Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. PerkinElmer Business Overview
Table 105. PerkinElmer Recent Developments
Table 106. QIAGEN Tumor Genomics Basic Information
Table 107. QIAGEN Tumor Genomics Product Overview
Table 108. QIAGEN Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. QIAGEN Business Overview
Table 110. QIAGEN Recent Developments
Table 111. Siemens Healthineers AG Tumor Genomics Basic Information
Table 112. Siemens Healthineers AG Tumor Genomics Product Overview
Table 113. Siemens Healthineers AG Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Siemens Healthineers AG Business Overview
Table 115. Siemens Healthineers AG Recent Developments
Table 116. Thermo Fisher Scientific Inc. Tumor Genomics Basic Information
Table 117. Thermo Fisher Scientific Inc. Tumor Genomics Product Overview
Table 118. Thermo Fisher Scientific Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Thermo Fisher Scientific Inc. Business Overview
Table 120. Thermo Fisher Scientific Inc. Recent Developments
Table 121. Global Tumor Genomics Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Tumor Genomics Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Tumor Genomics Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Tumor Genomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Tumor Genomics Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Tumor Genomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Tumor Genomics Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Tumor Genomics Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Tumor Genomics Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Tumor Genomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Tumor Genomics Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Tumor Genomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Tumor Genomics Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Tumor Genomics Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Tumor Genomics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Tumor Genomics Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Tumor Genomics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tumor Genomics Market Size Comparison by Region (M USD)
Table 5. Global Tumor Genomics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Tumor Genomics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tumor Genomics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tumor Genomics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2022)
Table 10. Global Market Tumor Genomics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tumor Genomics Sales Sites and Area Served
Table 12. Manufacturers Tumor Genomics Product Type
Table 13. Global Tumor Genomics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tumor Genomics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tumor Genomics Market Challenges
Table 22. Global Tumor Genomics Sales by Type (K Units)
Table 23. Global Tumor Genomics Market Size by Type (M USD)
Table 24. Global Tumor Genomics Sales (K Units) by Type (2019-2024)
Table 25. Global Tumor Genomics Sales Market Share by Type (2019-2024)
Table 26. Global Tumor Genomics Market Size (M USD) by Type (2019-2024)
Table 27. Global Tumor Genomics Market Size Share by Type (2019-2024)
Table 28. Global Tumor Genomics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Tumor Genomics Sales (K Units) by Application
Table 30. Global Tumor Genomics Market Size by Application
Table 31. Global Tumor Genomics Sales by Application (2019-2024) & (K Units)
Table 32. Global Tumor Genomics Sales Market Share by Application (2019-2024)
Table 33. Global Tumor Genomics Sales by Application (2019-2024) & (M USD)
Table 34. Global Tumor Genomics Market Share by Application (2019-2024)
Table 35. Global Tumor Genomics Sales Growth Rate by Application (2019-2024)
Table 36. Global Tumor Genomics Sales by Region (2019-2024) & (K Units)
Table 37. Global Tumor Genomics Sales Market Share by Region (2019-2024)
Table 38. North America Tumor Genomics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Tumor Genomics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Tumor Genomics Sales by Region (2019-2024) & (K Units)
Table 41. South America Tumor Genomics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Tumor Genomics Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Laboratories Tumor Genomics Basic Information
Table 44. Abbott Laboratories Tumor Genomics Product Overview
Table 45. Abbott Laboratories Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Laboratories Business Overview
Table 47. Abbott Laboratories Tumor Genomics SWOT Analysis
Table 48. Abbott Laboratories Recent Developments
Table 49. Agilent Technologies, Inc Tumor Genomics Basic Information
Table 50. Agilent Technologies, Inc Tumor Genomics Product Overview
Table 51. Agilent Technologies, Inc Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Agilent Technologies, Inc Business Overview
Table 53. Agilent Technologies, Inc Tumor Genomics SWOT Analysis
Table 54. Agilent Technologies, Inc Recent Developments
Table 55. Bio-Rad Laboratories, Inc. Tumor Genomics Basic Information
Table 56. Bio-Rad Laboratories, Inc. Tumor Genomics Product Overview
Table 57. Bio-Rad Laboratories, Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bio-Rad Laboratories, Inc. Tumor Genomics SWOT Analysis
Table 59. Bio-Rad Laboratories, Inc. Business Overview
Table 60. Bio-Rad Laboratories, Inc. Recent Developments
Table 61. Danaher Corporation Tumor Genomics Basic Information
Table 62. Danaher Corporation Tumor Genomics Product Overview
Table 63. Danaher Corporation Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Danaher Corporation Business Overview
Table 65. Danaher Corporation Recent Developments
Table 66. F. Hoffmann-La Roche Ltd Tumor Genomics Basic Information
Table 67. F. Hoffmann-La Roche Ltd Tumor Genomics Product Overview
Table 68. F. Hoffmann-La Roche Ltd Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. F. Hoffmann-La Roche Ltd Business Overview
Table 70. F. Hoffmann-La Roche Ltd Recent Developments
Table 71. Fluidigm Corporation Tumor Genomics Basic Information
Table 72. Fluidigm Corporation Tumor Genomics Product Overview
Table 73. Fluidigm Corporation Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Fluidigm Corporation Business Overview
Table 75. Fluidigm Corporation Recent Developments
Table 76. General Electric Company Tumor Genomics Basic Information
Table 77. General Electric Company Tumor Genomics Product Overview
Table 78. General Electric Company Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. General Electric Company Business Overview
Table 80. General Electric Company Recent Developments
Table 81. Illumina, Inc. Tumor Genomics Basic Information
Table 82. Illumina, Inc. Tumor Genomics Product Overview
Table 83. Illumina, Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Illumina, Inc. Business Overview
Table 85. Illumina, Inc. Recent Developments
Table 86. Merck KGaA Tumor Genomics Basic Information
Table 87. Merck KGaA Tumor Genomics Product Overview
Table 88. Merck KGaA Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Merck KGaA Business Overview
Table 90. Merck KGaA Recent Developments
Table 91. Myriad Genetics, Inc. Tumor Genomics Basic Information
Table 92. Myriad Genetics, Inc. Tumor Genomics Product Overview
Table 93. Myriad Genetics, Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Myriad Genetics, Inc. Business Overview
Table 95. Myriad Genetics, Inc. Recent Developments
Table 96. Pacific Biosciences of California, Inc. Tumor Genomics Basic Information
Table 97. Pacific Biosciences of California, Inc. Tumor Genomics Product Overview
Table 98. Pacific Biosciences of California, Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pacific Biosciences of California, Inc. Business Overview
Table 100. Pacific Biosciences of California, Inc. Recent Developments
Table 101. PerkinElmer Tumor Genomics Basic Information
Table 102. PerkinElmer Tumor Genomics Product Overview
Table 103. PerkinElmer Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. PerkinElmer Business Overview
Table 105. PerkinElmer Recent Developments
Table 106. QIAGEN Tumor Genomics Basic Information
Table 107. QIAGEN Tumor Genomics Product Overview
Table 108. QIAGEN Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. QIAGEN Business Overview
Table 110. QIAGEN Recent Developments
Table 111. Siemens Healthineers AG Tumor Genomics Basic Information
Table 112. Siemens Healthineers AG Tumor Genomics Product Overview
Table 113. Siemens Healthineers AG Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Siemens Healthineers AG Business Overview
Table 115. Siemens Healthineers AG Recent Developments
Table 116. Thermo Fisher Scientific Inc. Tumor Genomics Basic Information
Table 117. Thermo Fisher Scientific Inc. Tumor Genomics Product Overview
Table 118. Thermo Fisher Scientific Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Thermo Fisher Scientific Inc. Business Overview
Table 120. Thermo Fisher Scientific Inc. Recent Developments
Table 121. Global Tumor Genomics Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Tumor Genomics Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Tumor Genomics Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Tumor Genomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Tumor Genomics Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Tumor Genomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Tumor Genomics Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Tumor Genomics Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Tumor Genomics Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Tumor Genomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Tumor Genomics Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Tumor Genomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Tumor Genomics Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Tumor Genomics Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Tumor Genomics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Tumor Genomics Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Tumor Genomics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Tumor Genomics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tumor Genomics Market Size (M USD), 2019-2030
Figure 5. Global Tumor Genomics Market Size (M USD) (2019-2030)
Figure 6. Global Tumor Genomics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tumor Genomics Market Size by Country (M USD)
Figure 11. Tumor Genomics Sales Share by Manufacturers in 2023
Figure 12. Global Tumor Genomics Revenue Share by Manufacturers in 2023
Figure 13. Tumor Genomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tumor Genomics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tumor Genomics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tumor Genomics Market Share by Type
Figure 18. Sales Market Share of Tumor Genomics by Type (2019-2024)
Figure 19. Sales Market Share of Tumor Genomics by Type in 2023
Figure 20. Market Size Share of Tumor Genomics by Type (2019-2024)
Figure 21. Market Size Market Share of Tumor Genomics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tumor Genomics Market Share by Application
Figure 24. Global Tumor Genomics Sales Market Share by Application (2019-2024)
Figure 25. Global Tumor Genomics Sales Market Share by Application in 2023
Figure 26. Global Tumor Genomics Market Share by Application (2019-2024)
Figure 27. Global Tumor Genomics Market Share by Application in 2023
Figure 28. Global Tumor Genomics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tumor Genomics Sales Market Share by Region (2019-2024)
Figure 30. North America Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Tumor Genomics Sales Market Share by Country in 2023
Figure 32. U.S. Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Tumor Genomics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Tumor Genomics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Tumor Genomics Sales Market Share by Country in 2023
Figure 37. Germany Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Tumor Genomics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Tumor Genomics Sales Market Share by Region in 2023
Figure 44. China Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Tumor Genomics Sales and Growth Rate (K Units)
Figure 50. South America Tumor Genomics Sales Market Share by Country in 2023
Figure 51. Brazil Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Tumor Genomics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Tumor Genomics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Tumor Genomics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Tumor Genomics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tumor Genomics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tumor Genomics Market Share Forecast by Type (2025-2030)
Figure 65. Global Tumor Genomics Sales Forecast by Application (2025-2030)
Figure 66. Global Tumor Genomics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Tumor Genomics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tumor Genomics Market Size (M USD), 2019-2030
Figure 5. Global Tumor Genomics Market Size (M USD) (2019-2030)
Figure 6. Global Tumor Genomics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tumor Genomics Market Size by Country (M USD)
Figure 11. Tumor Genomics Sales Share by Manufacturers in 2023
Figure 12. Global Tumor Genomics Revenue Share by Manufacturers in 2023
Figure 13. Tumor Genomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tumor Genomics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tumor Genomics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tumor Genomics Market Share by Type
Figure 18. Sales Market Share of Tumor Genomics by Type (2019-2024)
Figure 19. Sales Market Share of Tumor Genomics by Type in 2023
Figure 20. Market Size Share of Tumor Genomics by Type (2019-2024)
Figure 21. Market Size Market Share of Tumor Genomics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tumor Genomics Market Share by Application
Figure 24. Global Tumor Genomics Sales Market Share by Application (2019-2024)
Figure 25. Global Tumor Genomics Sales Market Share by Application in 2023
Figure 26. Global Tumor Genomics Market Share by Application (2019-2024)
Figure 27. Global Tumor Genomics Market Share by Application in 2023
Figure 28. Global Tumor Genomics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tumor Genomics Sales Market Share by Region (2019-2024)
Figure 30. North America Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Tumor Genomics Sales Market Share by Country in 2023
Figure 32. U.S. Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Tumor Genomics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Tumor Genomics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Tumor Genomics Sales Market Share by Country in 2023
Figure 37. Germany Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Tumor Genomics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Tumor Genomics Sales Market Share by Region in 2023
Figure 44. China Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Tumor Genomics Sales and Growth Rate (K Units)
Figure 50. South America Tumor Genomics Sales Market Share by Country in 2023
Figure 51. Brazil Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Tumor Genomics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Tumor Genomics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Tumor Genomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Tumor Genomics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Tumor Genomics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tumor Genomics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tumor Genomics Market Share Forecast by Type (2025-2030)
Figure 65. Global Tumor Genomics Sales Forecast by Application (2025-2030)
Figure 66. Global Tumor Genomics Market Share Forecast by Application (2025-2030)
